Inhaler Usage Data Predictive Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing respiratory diseases such as asthma and COPD lack the ability to predict impending exacerbations, leading to unscheduled medical visits and potential life-threatening situations, as they do not effectively monitor changes in patient symptoms or inhaler usage patterns over time.
Innovation Solution
A method that uses an inhaler with a use determination system to track rescue medicament usage, generating a comparator variable by comparing baseline and current usage statistics, which is then input into a trained machine learning model to assess the respiratory disease status, allowing for pre-emptive treatment and reducing the risk of exacerbations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional respiratory disease assessment methods are used, then the assessment process is simple, but the ability to predict impending exacerbations is insufficient
Solution Approach 1:
The system performs preliminary analysis by collecting inhaler usage data over time and comparing current usage patterns against historical baselines before exacerbations occur. This early detection capability allows for pre-emptive treatment, predicting respiratory deterioration before it becomes severe enough to require emergency medical intervention.
Solution Approach 2:
The system introduces an intermediary assessment layer between traditional clinical visits and actual exacerbation events. By using machine learning models to analyze inhaler usage patterns as an intermediate indicator, the system provides continuous monitoring that bridges the gap between periodic medical appointments and real-time patient status.
2Measurement precision
If continuous monitoring of inhaler usage is implemented, then early detection of exacerbations is improved, but the complexity of data processing increases
Solution Approach 1:
The system employs self-service mechanisms where the machine learning model automatically learns from historical inhaler usage data and continuously refines its own prediction algorithms. The system serves itself by automatically updating its baseline comparisons and adjustment factors without requiring manual recalibration, reducing the operational complexity despite increased monitoring precision.
Solution Approach 2:
The system dynamically adjusts comparison parameters by modifying baseline periods and statistical thresholds based on individual patient patterns. The machine learning model changes its analysis parameters adaptively, adjusting the weight and timing of baseline comparisons to optimize detection precision while managing processing complexity through intelligent parameter selection.
Data Source
AI summary
Provided is a method for generating an assessment of a respiratory disease in a subject at a current point in time. The method comprises determining a baseline statistic relating to usage of an inhaler in a baseline period. The inhaler is configured to deliver a rescue medicament to the subject, and has a use determination system configured to determine usage of the inhaler by the subject. The method also comprises determining a current statistic relating to usage of the inhaler in a current period containing the current point in time. The method further comprises generating a comparator variable. Generating the comparator variable comprises comparing the current statistic and the baseline statistic. The assessment of the respiratory disease is based on the comparator variable.